Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7539685

Concept 2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
2022-04-01 to
2022-09-30
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
44,000,000 JPY
3,641,000,000 JPY
3,658,000,000 JPY
3,055,000,000 JPY
-585,000,000 JPY
-61,000,000 JPY
231,000,000 JPY
3,141,000,000 JPY
-473,000,000 JPY
-20,000,000 JPY
3,352,000,000 JPY
2,879,000,000 JPY
Non-operating income
Non-operating income
224,000,000 JPY
236,000,000 JPY
Non-operating expenses
Non-operating expenses
183,000,000 JPY
128,000,000 JPY
Ordinary profit (loss)
3,096,000,000 JPY
2,987,000,000 JPY
Extraordinary income
Extraordinary income
2,314,000,000 JPY
32,000,000 JPY
Profit (loss) before income taxes
5,410,000,000 JPY
3,019,000,000 JPY
Income taxes - current
1,424,000,000 JPY
693,000,000 JPY
Income taxes - deferred
-143,000,000 JPY
-19,000,000 JPY
Profit (loss)
4,129,000,000 JPY
2,346,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.